|
(BS39) |
Modulation of the sympathetic nervous system attenuates aortic distensibility and compliance in ApoE-deficient rats independent of blood pressure reduction |
| |
|
M. Hohl, D. Linz, P. Fries, A. Müller, T. Speer, D. Urban, M. Wolf, J. Geisel, S. H. Schirmer, M. Böhm, F. Mahfoud (Homburg/Saar) |
|
(BS40) |
MicroRNA-based therapy of Gata2-deficient vascular disease |
| |
|
D. Hartmann, K. Sonnenschein, J. Fiedler, T. Thum (Hannover) |
|
(BS41) |
Asymmetric dimethylarginine induces endothelial dysfunction via microRNA-126 modulation |
| |
|
C. Bang, F. Martino, F. Schöttmer, J. Kielstein, J. Lorenzen, T. Thum (Hannover) |
|
(BS42) |
rAAV.MRTF-A induces therapeutic neovascularization via vessel maturation: Role of early vessel destabilisation |
| |
|
M. Kraus, R. Hinkel, T. Trenkwalder, F. Gesenhues, A. Howe, S. Lee, C. Kupatt (München) |
|
(BS43) |
Angiotensin II-and High Fat Diet-induced Atherosclerosis is Attenuated in Skp2-deficienct Mice |
| |
|
T. Johannsen, P. Lacour, K. Kappert, A. Heuser, J. Drenckhahn, L. Thierfelder, B. Pieske, F. Blaschke (Berlin) |
|
(BS44) |
Renal expression of novel biomarkers in experimental heart failure |
| |
|
J. Ingold, C. Birner, L. S. Maier, A. Luchner, C. G. Jungbauer (Straubing, Regensburg, Amberg) |
|
(BS45) |
Thymosin β4 and MRTF-A attenuate microcirculatory and hemodynamic destabilization in sepsis |
| |
|
D. Bongiovanni, T. Ziegler, J. Ng, S. d'Almeida, T. Zhang, R. Hinkel, C. Kupatt (München, Martinsried) |